FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of chemical-pharmaceutical industry, namely to novel anti-tuberculosis medication. Claimed medication contains as active substance 4-thioureidoiminomethyperidinium perchlorate in effective and safe quantity and pharmaceutically acceptable auxiliary substances. Also claimed is method of its obtaining, which makes it possible to obtain target product with high yield. Novel medication, obtained by claimed method, possesses high tuberculostatic activity and low toxicity, preserves its stability in long-term storage.
EFFECT: invention can be used for treatment of all forms of pulmonary and extra-pulmonary tuberculosis, as well as in prophylaxis in composition of combined tuberculosis therapy.
12 cl, 8 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2431487C2 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
PHARMACEUTICAL COMPOSITIONS OF ANTITUBERCULOSIS MEDICINAL AGENTS AND METHOD FOR THEIR PREPARING | 2001 |
|
RU2240795C9 |
METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
SYNERGIC ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSERINE AND ZINC CONTAINING CONNECTION | 2016 |
|
RU2620857C1 |
Authors
Dates
2011-07-20—Published
2010-04-20—Filed